395766004: Calcipotriol (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Vitamin\Fat-soluble vitamin\Vitamin D and/or vitamin D derivative\Calcipotriol (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid\Vitamin D and/or vitamin D derivative\Calcipotriol (substance)

\Biological substance\Nutrients\Vitamin\Fat-soluble vitamin\Vitamin D and/or vitamin D derivative\Calcipotriol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Calcipotriol (substance)	Is a	agent antimitotique	false	Inferred relationship	Some
Calcipotriol (substance)	Is a	agent topique cutané	false	Inferred relationship	Some
Calcipotriol (substance)	Is a	Vitamin D and/or vitamin D derivative	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriene 50micrograms/mL scalp solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Product containing calcipotriol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	1
Calcipotriene hydrate 0.005% cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriene 0.005% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriene 0.005% ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Product containing betamethasone and calcipotriol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	2
Calcipotriol adverse reaction	Causative agent (attribute)	True	Calcipotriol (substance)	Inferred relationship	Some	1
Allergy to calcipotriol	Causative agent (attribute)	False	Calcipotriol (substance)	Inferred relationship	Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriene 0.005%/betamethasone 0.064% topical suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriol 50 microgram/mL cutaneous foam	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Allergy to calcipotriol	Causative agent (attribute)	True	Calcipotriol (substance)	Inferred relationship	Some	1
Calcipotriol monohydrate (substance)	Is a	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriol hydrate	Is a	False	Calcipotriol (substance)	Inferred relationship	Some
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriol monohydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Calcipotriol (substance)	Inferred relationship	Some
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing calcipotriol in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	1
Betamethasone and calcipotriol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	2
Product containing only calcipotriol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing only calcipotriol in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Calcipotriol (substance)	Inferred relationship	Some	1
Calcipotriol 50 microgram/mL cutaneous foam	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Calcipotriol (substance)	Inferred relationship	Some	1
Calcipotriol 50 microgram/mL cutaneous foam	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Calcipotriol (substance)	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Calcipotriol (substance)	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Calcipotriol (substance)	Inferred relationship	Some	2
Betamethasone and calcipotriol only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	2
Product containing betamethasone and calcipotriol in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Calcipotriol (substance)	Inferred relationship	Some	2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Calcipotriol (substance)	Inferred relationship	Some	2
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Calcipotriol (substance)	Inferred relationship	Some	2
Calcipotriol anhydrous	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Calcipotriol (substance)	Inferred relationship	Some
Calcipotriol 50 microgram/g cutaneous cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Calcipotriol (substance)	Inferred relationship	Some	1
Calcipotriol 50 microgram/g cutaneous cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Calcipotriol (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469706014	Calcipotriol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489408015	Calcipotriol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2476991015	Calcipotriene	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54601000195114	calcipotriolo	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
796731000172118	calcipotriol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68971000195114	Calcipotriol	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module